MFN News
Language
Valberedningen i Boule Diagnostics AB föreslår årsstämman 2023 att styrelsen ska bestå av sex styrelseledamöter inklusive styrelseordförande. Valberedningen...
15 Mar, 2023
Boule Diagnostics AB: FUJIFILM och Boule utökar samarbetet till fler europeiska marknader
News
Swedish
IR
Boule Diagnostics och FUJIFILM har utökat det strategiska distributörsavtalet i Europa för veterinärlösningar. FUJIFILM började sälja Boules veterinärprodukter...
Boule Diagnostics och FUJIFILM har utökat det strategiska distributörsavtalet i Europa för veterinärlösningar. FUJIFILM började sälja Boules veterinärprodukter...
02 Feb, 2023
Boule Diagnostics AB: Boule Diagnostics (publ) bokslutskommuniké januari-december 2022
News
Swedish
Regulatory
Report
Annual
Interim
Yearend
IR
Förbättrad bruttomarginal för kvartalet Kvartalet oktober-december 2022 Helåret januari-december 2022 *Fondemissionselement från nyemissionen i Q4...
02 Feb, 2023
Boule Diagnostics (publ) bokslutskommuniké januari–december 2022
News
Swedish
Regulatory
MAR
Report
Interim
Yearend
IR
Förbättrad bruttomarginal för kvartalet Kvartalet oktober–december 2022 Helåret januari–december 2022 *Fondemissionselement från nyemissionen...
26 Jan, 2023
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av bokslutskommunikén 2022
News
Swedish
IR
Boule Diagnostics AB offentliggör bokslutskommunikén för perioden januari - december 2022 torsdagen den 2 februari 2023 klockan 7:30. Efter offentliggörandet...
26 Jan, 2023
Boule Diagnostics – Inbjudan till presentation av bokslutskommunikén 2022
News
Swedish
IR
Boule Diagnostics AB offentliggör bokslutskommunikén för perioden januari – december 2022 torsdagen den 2 februari 2023 klockan 7:30. Efter offentliggörandet...
30 Dec, 2022
Boule Diagnostics AB: Förändring av antalet aktier och röster i Boule Diagnostics
News
Swedish
Regulatory
IR
Stockholm, Sverige, 30 december 2022 - Boule Diagnostics AB (publ) ("Boule" eller "Bolaget") (Nasdaq Stockholm: BOUL) har, som tidigare offentliggjorts...
30 Dec, 2022
Förändring av antalet aktier och röster i Boule Diagnostics
News
Swedish
Regulatory
LHFI
IR
Stockholm, Sverige, 30 december 2022 - Boule Diagnostics AB (publ) (”Boule” eller ”Bolaget”) (Nasdaq Stockholm: BOUL) har, som tidigare offentliggjorts...
Boule Diagnostics AB har idag utsett Jan Benjaminson till interim CFO med tillträde den 3:e februari 2023. Jan tar över efter Annette Colin som sitter...
14 Dec, 2022
Boule Diagnostics AB: Boule Diagnostics utser Jan Benjaminson till interim CFO
News
Swedish
Regulatory
IR
Boule Diagnostics AB har idag utsett Jan Benjaminson till interim CFO med tillträde den 3:e februari 2023. Jan tar över efter Annette Colin som sitter...
30 Nov, 2022
Boule Diagnostics AB: Boule Diagnostics tillförs cirka 150 MSEK genom en signifikant övertecknad företrädesemission
News
Swedish
Regulatory
IR
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, BELARUS, KANADA, NYA ZEELAND, RYSSLAND...
03 Feb, 2021
Boule Diagnostics AB (publ) Year-end report January–December 2020
News
English
Regulatory
MAR
Report
Interim
Yearend
IR
Progress in development but the pandemic impact continued Significant events during the quarter
Boule´s proprietary technology at the core of the company’s...
Boule Diagnostics AB will publish the year-end report for the period January–December 2020 at 15:00, Wednesday, February 3rd, 2021. Following the publication...
22 Dec, 2020
Boule´s proprietary technology at the core of the new platform. Intangible assets are written down by SEK 40 million.
News
English
Regulatory
MAR
IR
The development of the next generation product platform has now reached a defining milestone regarding design, specification and choice of core technology...
05 Nov, 2020
Boule Diagnostics AB (publ) Interim report January–September 2020
News
English
Regulatory
MAR
Report
Interim
Q3
IR
Strong operating profit despite ongoing pandemic Significant events during the quarter
Boule strengthens innovation and product development and appoints...
Boule Diagnostics AB will publish the interim report for the period January–September 2020 at 15:00, Thursday, November 5th, 2020. Following the publication...
22 Oct, 2020
Boule Diagnostics – Nomination Committee for the 2021 Annual General Meeting
News
English
IR
The Annual General Meeting, (”AGM”), 2020 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership...
31 Aug, 2020
Boule has signed a long-term supply agreement with one of the company’s major OEM clients
News
English
IR
Boule Diagnostics AB has extended a longstanding partnership with a global leader in the diagnostics sector providing products and services for the hematology...
26 Aug, 2020
Boule strengthens innovation and product development and appoints Helena Börjesson as CTO
News
English
IR
Boule Diagnostics appoints Helena Börjesson as Chief Technology Officer (CTO) as of September 1, 2020. Helena has been with Boule in an interim position...
17 Jul, 2020
Boule Diagnostics AB (publ) Interim report January–June 2020
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
Continued business development in the shadow of COVID-19 The Board of Boule Diagnostics AB decided to withdraw the previously communicated dividend proposal...
10 Jul, 2020
Boule Diagnostics publishes the interim report Q2 2020 on July 17, 2020 at 08.00 CET
News
English
IR
Boule Diagnostics AB will bring the publishing of the interim report for the period January–June 2020 forward to 08:00, Friday, July 17th, 2020. The...
09 Jul, 2020
Boule Diagnostics AB writes-off the asset shares in Associate
News
English
Regulatory
MAR
IR
Following an impairment test of the associated company biosurfit, Boule Diagnostics have decided to write-off the entire shareholding in the associated...
07 May, 2020
Bulletin from Annual General Meeting in Boule Diagnostics AB on May 7, 2020
News
English
IR
The Annual General Meeting 2020 (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance...